Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites.
Department of Radiation Oncology, University of California San Francisco, CA, USA.
Christopher H
CH
Chapman
Department of Radiation Oncology, University of Washington, WA, USA.
Upendra
U
Parvathaneni
Department of Radiation Oncology, University of California San Francisco, CA, USA.
Sue S
SS
Yom
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D060828:Induction Chemotherapy; D009362:Neoplasm Metastasis; D059351:Organ Sparing Treatments; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome
D001952:Bridged-Ring Compounds; D043823:Taxoids; C080625:taxane
antineoplastic agents; antineoplastic combined chemotherapy protocols; carcinoma; chemotherapy; clinical trials; combined modality therapy; head and neck neoplasms; induction therapy; molecular-targeted therapy; neoadjuvant therapy; sequential therapy; squamous cell; treatment outcomes